Sotera Health Dirección
Dirección controles de criterios 3/4
El CEO de Sotera Health's es Michael Petras , nombrado en Jun 2016, tiene una permanencia de 7.83 años. compensación anual total es $9.70M, compuesta por 10.8% salario y 89.2% primas, incluidas acciones y opciones de la empresa. posee directamente un 1.98% de las acciones de la empresa, por valor de $63.50M. La antigüedad media del equipo directivo y de la junta directiva es de 3.5 años y 3.5 años, respectivamente.
Información clave
Michael Petras
Chief Executive Officer (CEO)
US$9.7m
Compensación total
| Porcentaje del salario del CEO | 10.8% |
| Permanencia del CEO | 7.9yrs |
| Participación del CEO | 2.0% |
| Permanencia media de la dirección | 3.6yrs |
| Promedio de permanencia en la Junta Directiva | 3.6yrs |
Actualizaciones recientes de la dirección
Recent updates
The Price Is Right For Sotera Health Company (NASDAQ:SHC) Even After Diving 29%
Mar 21
Sotera Health Company Just Missed Earnings - But Analysts Have Updated Their Models
Mar 01McIntyre Partnerships - Sotera Health Company: A Notable Outlier At A Discount
Feb 08Is Sotera Health (NASDAQ:SHC) A Risky Investment?
Feb 06Investors Still Aren't Entirely Convinced By Sotera Health Company's (NASDAQ:SHC) Revenues Despite 26% Price Jump
Dec 28Sotera Health Company's (NASDAQ:SHC) Intrinsic Value Is Potentially 33% Above Its Share Price
Dec 11An Intrinsic Calculation For Sotera Health Company (NASDAQ:SHC) Suggests It's 37% Undervalued
Sep 10Sotera Health Company (NASDAQ:SHC) Shares Could Be 24% Below Their Intrinsic Value Estimate
Jun 05Are Investors Undervaluing Sotera Health Company (NASDAQ:SHC) By 34%?
Feb 13Market Participants Recognise Sotera Health Company's (NASDAQ:SHC) Earnings Pushing Shares 29% Higher
Nov 24Sotera Health plunges 20% after jury awards $363M against its Sterigenics unit
Sep 19Are Investors Undervaluing Sotera Health Company (NASDAQ:SHC) By 49%?
Sep 08Sotera Health GAAP EPS of $0.11 misses by $0.05, revenue of $266.64M beats by $10.34M
Aug 04Is Sotera Health Company (NASDAQ:SHC) Trading At A 46% Discount?
May 09Returns On Capital Are Showing Encouraging Signs At Sotera Health (NASDAQ:SHC)
Mar 16Are Investors Undervaluing Sotera Health Company (NASDAQ:SHC) By 38%?
Jan 19A Look At The Fair Value Of Sotera Health Company (NASDAQ:SHC)
Sep 24Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | US$55m |
| Dec 31 2023 | US$10m | US$1m | US$51m |
| Sep 30 2023 | n/a | n/a | -US$306m |
| Jun 30 2023 | n/a | n/a | -US$268m |
| Mar 31 2023 | n/a | n/a | -US$261m |
| Dec 31 2022 | US$17m | US$1m | -US$234m |
| Sep 30 2022 | n/a | n/a | US$121m |
| Jun 30 2022 | n/a | n/a | US$123m |
| Mar 31 2022 | n/a | n/a | US$135m |
| Dec 31 2021 | US$2m | US$1m | US$115m |
| Sep 30 2021 | n/a | n/a | US$36m |
| Jun 30 2021 | n/a | n/a | US$9m |
| Mar 31 2021 | n/a | n/a | -US$26m |
| Dec 31 2020 | US$17m | US$728k | -US$39m |
| Sep 30 2020 | n/a | n/a | -US$23m |
| Jun 30 2020 | n/a | n/a | -US$28m |
| Mar 31 2020 | n/a | n/a | -US$29m |
| Dec 31 2019 | US$2m | US$700k | -US$21m |
Compensación vs. Mercado: La compensación total de Michael($USD9.70M) está por encima de la media de empresas de tamaño similar en el mercado US ($USD6.59M).
Compensación vs. Ingresos: La compensación de Michael ha sido consistente con los resultados de la empresa en el último año.
CEO
Michael Petras (54 yo)
7.9yrs
Permanencia
US$9,701,005
Compensación
Mr. Michael B. Petras Jr., serves as Chief Executive Officer at Sotera Health Company since June 20, 2016. He has been Chairman of the Board at Sotera Health Company since October 2020. He also served as t...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Chairman & CEO | 7.9yrs | US$9.70m | 1.98% $ 61.9m | |
| Senior VP & CFO | less than a year | US$2.18m | sin datos | |
| Senior VP | 1.5yrs | US$862.18k | 0.083% $ 2.6m | |
| President of Sterigenics | 3.6yrs | US$2.03m | 0.17% $ 5.3m | |
| Chief Information Officer | 5.3yrs | sin datos | sin datos | |
| Chief Marketing Officer | 7.5yrs | sin datos | sin datos | |
| Senior Vice President of Strategy & Corporate Development | 2.3yrs | sin datos | sin datos | |
| Chief Human Resources Officer | 5.3yrs | sin datos | sin datos | |
| Senior Vice President of Global Environmental | no data | sin datos | sin datos | |
| President of Nelson Labs | 3.6yrs | sin datos | sin datos | |
| President of Nordion | 2.3yrs | sin datos | sin datos | |
| VP & Treasurer | no data | sin datos | sin datos |
3.6yrs
Permanencia media
53.5yo
Promedio de edad
Equipo directivo experimentado: El equipo directivo de SHC se considera experimentado (3.5 años antigüedad media).
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Chairman & CEO | 7.9yrs | US$9.70m | 1.98% $ 61.9m | |
| Independent Director | 3.6yrs | US$302.50k | 0.0091% $ 285.3k | |
| Independent Director | 3.6yrs | US$320.00k | 0.0091% $ 285.3k | |
| Independent Director | 3.6yrs | US$305.00k | 0.0091% $ 285.3k | |
| Independent Director | 3.6yrs | US$302.50k | 0.0091% $ 285.3k | |
| Independent Director | 3.5yrs | US$325.00k | 0.0091% $ 285.3k | |
| Independent Director | 3.6yrs | US$322.50k | 0.025% $ 784.1k | |
| Independent Director | 1.6yrs | US$300.00k | 0% $ 0 | |
| Independent Director | 3.5yrs | US$302.50k | 0.0091% $ 285.3k | |
| Independent Director | 3yrs | US$310.00k | 0.0071% $ 220.6k | |
| Independent Director | less than a year | US$9.99k | sin datos |
3.6yrs
Permanencia media
60yo
Promedio de edad
Junta con experiencia: La junta directiva de SHC se considera experimentada (3.5 años de antigüedad promedio).